1Ruggenenti P,Pema A,Mosconi L,et al.Urnary protein excretion rate is the best independictor of ESRF in nondiabetrc proteinuric chronic nephropathies [J].Kidney Int,1998,53:1209.
2Jafar TH,Stork PC,Schmid CH,et al.Proteinuna as a modifiable risk factor for the progression of non-diabetic renal diseases [J].Kidney Int,2001,60:1131.
4Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med,1998,339:1 448
5Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int, 1997,51:2
6Ruggenenti P, Perna A, Mosconi L et al. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int, 1998,53:1 209
7Jafar TH, Stark PC, Schmid CH et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal diseases. Kidney Int,2001,60:1 131
8Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis,1996,27:765
9Arovin BH, Tan LC. LDL stimulates messangial fibronectin production and chemoattractant expression. Kidney Int, 1993,43:218
10Burton CJ, Harper SJ, Bailey E et al. Turnover of human tubular cells exposed to proteins in vivo and in vitro. Kidney Int,2001,59:507
7De jean A, Lugassy C, Zafrani S,et al. Delectied of hepatitis Bvirus DNA in pancreas, kidney and skin of two human carriers of the virus[J]. J Gen Virol,1984, 65(6) :651.
8Combes Bs, Shorey J , Bah'era A , et al. Clomerulone phritis with depo- sition of Australia antigen - antibody Complexes in glomerlovbose men- tmemhrane [ J ] . Lancet, 1971,7718 ( 2 ) : 234 - 237.
9Okuse C, Yotsuyanagi H, Yamada N, et at. Successful treatment of hepatitis B virus - associated membranous nephropathy with lamivudine [ J]. Clin Nephrol,2006,65 (10) :53 - 56.
10Wen YK, Chen ML. 13.emission of hepatitis B virusassociated membran- oproliferative glomerulonephritis in a cirrhotic patient after |amivudine lherapy [ J ]. Clin Nephro1,2006,65 (7) :211 - 215.
